RV021
Pre-clinical- Indications
- Rabies
Company intelligence / Profile preview
Hongene Biotech is a global leader in the manufacture and supply of nucleic acid raw materials—including nucleosides, modified nucleosides, nucleotides, phosphoramidites, cap analogs, GalNAc conjugates, and enzymes—for use in RNA therapeutics and diagnostics. The company operates as both a specialist CDMO and supplier to pharmaceutical/biotechnology companies developing mRNA vaccines/therapies and oligonucleotide drugs worldwide[1][2][4][6]. During the COVID‑19 pandemic it was the largest supplier of raw materials used in billions of mRNA vaccine doses[6].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hongene Biotech.